Home>Topics>Companies>Bayer AG

Bayer AG

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. ETF Reports
  6. Headlines
  1. New Morningstar Analyst Report for Bayer AG

    Stock Reports

    Thu, 18 Sep 2014

    declines in Betaseron, a top drug for Bayer .Both the material science and the ..... differentiation from the older version. Bayer is in the midst of launching several ..... drugs that hold blockbuster potential. Bayer 's strong entrenchment in biologics

  2. BRIEF- Bayer seen up 2.3 pct after plastics spin-off report

    Headlines

    Thu, 18 Sep 2014

    Sept 18 (Reuters) - Bayer AG : * Shares indicated up 2.3 percent after report it plans to separate its

  3. Bayer to unveil plan to sell plastics business- WSJ Deutschland

    Headlines

    Wed, 17 Sep 2014

    FRANKFURT, Sept 18 (Reuters) - Bayer plans to sell its plastics business with an estimated value of about 8 billion euros ($10.3 billion) as part of a shift away from chemicals towards pharmaceuticals and crop science, a German newspaper reported, citing informed sources.

  4. BRIEF- Bayer , Orion start phase III trial of prostate cancer agent

    Headlines

    Tue, 16 Sep 2014

    Sept 16 (Reuters) - Bayer AG : * Says initiates phase III trial of ODM-201 in men with high-risk

  5. UPDATE 2-U.S. seeks to hold Bayer in contempt over product health claims

    Headlines

    Fri, 12 Sep 2014

    WASHINGTON, Sept 12 (Reuters) - The American unit of Bayer AG is making unsubstantiated claims about its Phillips Colon Health product, the United States said on Friday as it sought to hold Bayer ...

  6. New Morningstar Analyst Report for Mallinckrodt PLC

    Stock Reports

    Tue, 9 Sep 2014

    Covidien, he was CEO of Bayer Healthcare 's U.S. pharmaceutical ..... experience at a firm like Bayer , which also has a broad ..... four segments: generic pharmaceuticals , branded pharmaceuticals , nuclear imaging, and

  7. BRIEF- Bayer says safety of Adempas confirmed by results of long-term studies

    Headlines

    Mon, 8 Sep 2014

    Sept 8 (Reuters) - Bayer AG : * Says safety and sustained benefits of adempas from Bayer confirmed by

  8. Spectrum Pharmaceuticals : A Long-Term Bet

    Headlines

    Thu, 28 Aug 2014

    By Samreen Agha : Spectrum Pharmaceuticals , Inc. ( SPPI ) is a small-cap biotechnology ..... with a number of companies, such as Hanmi Pharmaceuticals , Ligand Pharmaceuticals , Bayer , Biogen Idec, Mundipharma, TopoTarget

  9. Gilead: Let's Make A Deal

    Headlines

    Thu, 28 Aug 2014

    Gilead is now a larger company ($160 B market cap) than many familiar pharma names including Sanofi, Lilly, AbbVie, Bayer AG , Bristol-Myers-Squibb, GlaxoSmithKline, AstraZeneca, Novo Nordisk, and Amgen. Gilead is rapidly approaching the

  10. Why I Bought Into Monday's Move In Regeneron

    Headlines

    Tue, 26 Aug 2014

    major pharma company Sanofi (NYSE: SNY ). In addition to growth in ophthalmology, with which REGN partners with Bayer Healthcare , the greatest amount of pipeline excitement comes from the REGN injectable protein alirocumab. This is a cholesterol

« Prev12345Next »
Content Partners